Nasivion® Mini (Baby) Nose Drops
Better breathing for improved eating and sleeping when baby has a bout of rhinitis.
INGREDIENTS Each ml of Nasivion® Baby Nose Drops contains: - 0.01 mg Oxymetazoline Hydrochloride USP (active ingredient) in buffered aqueous solution - 0.3 mg Benzalkonium Chloride Solution 50% IP (as preservative) | PRESENTATION
10 ml glass bottle with dropper |
DOSAGE AND FREQUENCY OF USE Intranasal administration for infants below one year. Up to the age of 4 weeks, instill 1 drop of the solution into each nostril 2-3 times per day. From the 5th week of life until the age of 1 year, instill 1-2 drops into each nostril 2-3 times per day or as directed by the physician. Oxymetazoline Hydrochloride containing nasal drops should not be used for longer than 10 consecutive days. A treatment free period of several days should precede any repeated use. Medical supervision is indicated in pre-mature or underweight new-borns to avoid the risk of over-dosage. | STORAGE INSTRUCTIONS Preserve in tight containers at a temperature not exceeding 30°C Do not use if seal is broken Close the cap tightly after use Keep out of reach of children |
Then the baby will be able to breathe freely for up to 12 hours.2 2Martindale. Thirty-eighth edition. The complete drug reference. Oxymetazoline Hydrochloride. Editor: Thomson Reuters. |
DID YOU KNOW?
There are lots of small things you can do to help alleviate the discomfort of rhinitis for your baby. Give your little one plenty of liquids – the nursing or bottle also provides a bit of comfort. Create a steam room to reduce stuffiness or use a saline solution nasal spray to clean the nose and loosen up the mucus.
RELATED PRODUCTS
INTERESTING ARTICLES
1Deitmer T and Scheffler R. The effect of different preparations of nasal decongestants on ciliary beat frequency in vitro. Rhinology 1993;31:151-153.
2Martindale. Thirty-eighth edition. The complete drug reference. Oxymetazoline Hydrochloride. Editor: Thomson Reuters.
The 25 sec onset of action evidence pertains to a clinical study in adults with formulation containing 0.05% Oxymetazoline HCL